Feedback
The current prices are delayed. Login to see live prices.
AstraZeneca Pharma India Ltd.
(ASTRAZEN)
60123456789,801234567897012345678900123456789.3012345678900123456789
-105.50 (-1.51%)
Updated 15:55 21/02 IST
Add
1D
5D
1M
3M
1Y
5Y
MAX
Today's low
₹6,808.15
Today's high
₹7,022.6
52 week low
₹3,098
52 week high
₹8,139
Open
₹6,978.7
Prev Close
₹6,975.8
Volume (shares)
6,305
Total Trading Value
4.4 Cr
Technicals
SMA
Value
Signal
12-SMA
7,245.35
Bearish
20-SMA
7,273.65
Bearish
50-SMA
7,020.92
Bearish
100-SMA
7,076.24
Bearish
200-SMA
6,815.88
Bullish
Discussions
• Feb 16 1:40 AM
Investing in ETFs made simple 101
Hello,...read more
• Feb 15 1:02 AM
AstraZeneca Updates on Manufacturing Site Closure
• AstraZeneca plans to exit its manufacturing site, exploring potent...read more
• Feb 14 5:41 AM
Astrazeneca Pharma I - Quarterly Results
Earnings Update...read more
• Feb 12 1:18 AM
AstraZeneca Reports 44% Revenue Growth in Q3 Financial Results
• AstraZeneca Pharma India Ltd reported a 44% increase in revenue fo...read more
• Feb 12 1:18 AM
AstraZeneca Reports Strong Q3 Results with 44% Revenue Growth
• AstraZeneca Pharma India reported a 44% increase in revenue for Q3...read more
• Feb 12 1:02 AM
AstraZeneca India Reports 44% Revenue Growth in Q3 2024
• AstraZeneca Pharma India achieved a 44% revenue increase in Q3 202...read more
• Feb 12 12:37 AM
AstraZeneca Reports Strong Q3 Financial Results with 44% Revenue Increase
• AstraZeneca reported a 44% revenue increase for Q3 ended December ...read more
• Feb 12 12:37 AM
AstraZeneca Receives BSE Warning for Audit Committee Compliance Issue
• AstraZeneca received a warning letter from BSE for not meeting quo...read more
• Feb 11 11:37 PM
AstraZeneca Appoints Dr. Sandeep Arora as Director of Medical Affairs
• Dr. Sandeep Arora has been appointed as Director – Medical Affairs...read more
• Feb 10 9:32 PM
AstraZeneca Receives Warning Letter from NSE for Governance Non-Compliance
• AstraZeneca Pharma India Limited received a warning letter from th...read more
• Feb 10 9:31 PM
AstraZeneca Files Compliance Certificate Under SEBI Regulations
• AstraZeneca Pharma India Limited submitted a compliance certificat...read more
• Feb 10 9:16 PM
AstraZeneca Receives Warning from NSE for Audit Committee Compliance Lapse
• AstraZeneca has received a warning letter from NSE for failing to ...read more
• Feb 10 9:16 PM
AstraZeneca Compliance Certificate Under SEBI Regulation 74(5)
• AstraZeneca Pharma India Ltd. submitted a compliance certificate t...read more
• Feb 10 12:30 AM
• Feb 1 10:16 PM
ASTRAZENECA
A good trendline breakout with higher highs & stock surp...read more
1
1
1
• Feb 1 10:14 PM
ASTRAZENECA
A good trendline breakout with higher highs & stock surp...read more
1
Load More Posts
Frequently Asked Questions (FAQs)
What is the Share Price of AstraZeneca Pharma India Ltd. ?
The share prices are volatile and fluctuate throughout the trading hours. The share price of AstraZeneca Pharma India Ltd. is Rs 6975.8 as of 21 February 2025.
What is the Market Capitalization of AstraZeneca Pharma India Ltd. ?
The current market cap of AstraZeneca Pharma India Ltd. is undefined Market capitalisation is calculated by multiplying the current share price with the total number of shares.
What are the PE and PB ratios of AstraZeneca Pharma India Ltd.?
AstraZeneca Pharma India Ltd. has a price-to-earnings (PE) ratio of undefined and a price-to-book (PB) ratio of undefined.
What is the 52-week high/low of AstraZeneca Pharma India Ltd.?
The 52-week high of AstraZeneca Pharma India Ltd. is Rs 8139 and the 52-week low is Rs 3098
Join 10,00,000 Indian traders and discuss trades, strategies, news & views on any stock.
Create your account on Frontpage
FrontPage © 2025